Pages that link to "Q35998559"

The following pages link to Targeting antibody responses to the membrane proximal external region of the envelope glycoprotein of human immunodeficiency virus (Q35998559):

Displaying 15 items.

• Recognition of membrane-bound fusion-peptide/MPER complexes by the HIV-1 neutralizing 2F5 antibody: implications for anti-2F5 immunogenicity (Q28484544) (← links)
• Multi-Parameter Exploration of HIV-1 Virus-Like Particles as Neutralizing Antibody Immunogens in Guinea Pigs, Rabbits and Macaques (Q33683203) (← links)
• A fusion intermediate gp41 immunogen elicits neutralizing antibodies to HIV-1 (Q34396912) (← links)
• Multimeric scaffolds displaying the HIV-1 envelope MPER induce MPER-specific antibodies and cross-neutralizing antibodies when co-immunized with gp160 DNA (Q34712503) (← links)
• Liposomal vaccines incorporating molecular adjuvants and intrastructural T-cell help promote the immunogenicity of HIV membrane-proximal external region peptides. (Q35034311) (← links)
• Immunogenic properties of a trimeric gp41-based immunogen containing an exposed membrane-proximal external region (Q36372534) (← links)
• Forced virus evolution reveals functional crosstalk between the disulfide bonded region and membrane proximal ectodomain region of HIV-1 gp41 (Q36814871) (← links)
• Modulating immunogenic properties of HIV-1 gp41 membrane-proximal external region by destabilizing six-helix bundle structure (Q36978277) (← links)
• Enhancing the Quality of Antibodies to HIV-1 Envelope by GagPol-Specific Th Cells (Q38827936) (← links)
• Eliciting neutralizing antibodies against the membrane proximal external region of HIV-1 Env by chimeric live attenuated influenza A virus vaccines (Q38989627) (← links)
• Immunologic Insights on the Membrane Proximal External Region: A Major Human Immunodeficiency Virus Type-1 Vaccine Target. (Q41925820) (← links)
• Development and immunological assessment of VLP-based immunogens exposing the membrane-proximal region of the HIV-1 gp41 protein (Q42197619) (← links)
• HIV-derived lentiviral particles promote T-cell independent activation and differentiation of naïve cognate conventional B2-cells in vitro (Q42270204) (← links)
• Intrastructural Help: Harnessing T Helper Cells Induced by Licensed Vaccines for Improvement of HIV Env Antibody Responses to Virus-Like Particle Vaccines. (Q55433971) (← links)
• Evolution of New Variants/Mutants of JE Virus, Its Effect on Neurovirulence, Antigenicity, Host Immune Responses and Disease Transmission in Endemic Areas (Q59049769) (← links)